These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7984887

  • 1. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA.
    Rev Prat; 1994 Oct 01; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract] [Full Text] [Related]

  • 2. Proton pump inhibitors.
    Grover JK, Vats V.
    Trop Gastroenterol; 1999 Oct 01; 20(1):16-28. PubMed ID: 10464444
    [No Abstract] [Full Text] [Related]

  • 3. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P, Fuchs W, Peifer-Weiss A, Simon B.
    Fortschr Med; 1998 Oct 10; 116(28):31-2. PubMed ID: 9844264
    [No Abstract] [Full Text] [Related]

  • 4. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
    Gillessen A.
    MMW Fortschr Med; 2004 Mar 11; 146(11):54. PubMed ID: 15152771
    [No Abstract] [Full Text] [Related]

  • 5. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    Dohmen W, Fuchs W.
    MMW Fortschr Med; 2005 Mar 03; 147(9):39. PubMed ID: 15794353
    [No Abstract] [Full Text] [Related]

  • 6. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Rubinić M, Ivandić A, Ivanis N, Horvat D, Volarić M, Karner I.
    Acta Med Croatica; 1997 Mar 03; 51(3):171-4. PubMed ID: 9248117
    [Abstract] [Full Text] [Related]

  • 7. Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis?
    Kim JD.
    J Fam Pract; 2002 Apr 03; 51(4):384. PubMed ID: 11978268
    [No Abstract] [Full Text] [Related]

  • 8. Asymptomatic giardiasis--an association with proton pump inhibitors?
    Mukherjee S.
    Am J Gastroenterol; 2000 Dec 03; 95(12):3666-7. PubMed ID: 11151928
    [No Abstract] [Full Text] [Related]

  • 9. [Acid inhibitors for asthma patients].
    Füessl HS.
    MMW Fortschr Med; 2005 Oct 20; 147(42):4-5. PubMed ID: 16281772
    [No Abstract] [Full Text] [Related]

  • 10. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO.
    Rev Gastroenterol Disord; 2006 Oct 20; 6(3):136-45. PubMed ID: 16957654
    [Abstract] [Full Text] [Related]

  • 11. [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA, Lipatova TE, Chaplygin NV.
    Eksp Klin Gastroenterol; 2002 Oct 20; (2):43-6, 102. PubMed ID: 12046386
    [Abstract] [Full Text] [Related]

  • 12. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA, Lipatova TE, Chaplygin NV.
    Eksp Klin Gastroenterol; 2002 Oct 20; (4):23-6, 131. PubMed ID: 12503269
    [Abstract] [Full Text] [Related]

  • 13. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug 20; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 14. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
    Am J Gastroenterol; 1998 Feb 20; 93(2):238-43. PubMed ID: 9468251
    [Abstract] [Full Text] [Related]

  • 15. [Medical treatment of gastroesophageal reflux with proton pump inhibitors].
    Vallot T, Carella G.
    Gastroenterol Clin Biol; 1999 Jan 20; 23(1 Pt 2):S97-109. PubMed ID: 10078438
    [No Abstract] [Full Text] [Related]

  • 16. [Current concepts in therapy of reflux disease].
    Kirchgatterer A, Aschl G, Hinterreiter M, Stadler B, Knoflach P.
    Wien Med Wochenschr; 2001 Jan 20; 151(11-12):266-9. PubMed ID: 11515224
    [Abstract] [Full Text] [Related]

  • 17. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec 20; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 18. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE.
    Am J Gastroenterol; 1997 Apr 20; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [Abstract] [Full Text] [Related]

  • 19. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA, Babkova IV, Mikhalev AI.
    Klin Med (Mosk); 2002 Apr 20; 80(9):52-4. PubMed ID: 12416227
    [Abstract] [Full Text] [Related]

  • 20. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
    Morreale A.
    Manag Care Interface; 2001 Apr 20; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.